Roche CEO Thomas Schinecker said in a statement on Tuesday that the company’s new $50 billion investment demonstrated its ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

The Swiss medication giant reported three meetings with federal officials in the past week, two of which were with Health ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

The Delhi High Court has rejected an interim injunction plea from Swiss pharma major F Hoffmann La Roche against Hyderabad-based Natco Pharma in a patent infringement dispute related to the former's ...

Roche has announced plans to invest $50 billion in the United States over the next five years, with funds earmarked for ...

The Study[2], sponsored by F. Hoffmann-La Roche (Roche), the fifth-largest pharmaceutical company in the world by revenue[3], presents a novel approach to improving the validity of clinical ...

The POLARIX study was sponsored by F. Hoffmann-La Roche Ltd. and Genentech, Inc. Bei Hu, MD, disclosed relationships with ADC Therapeutics, BeiGene, F. Hoffmann-La Roche Ltd./Genentech ...

The Study[2], sponsored by F. Hoffmann-La Roche (Roche), the fifth-largest pharmaceutical company in the world by revenue[3], presents a novel approach to improving the validity of clinical ...